When combined with paclitaxel, it downregulated the MDR1 gene expression in MCF7/ADM human breast cancer cell line; moreover, cytosolic glutathione S-transferase was also downregulated, which is a commonly expressed antioxidant system in resistant cancer [123,124]. The gene discussed is ABCB1; the disease is breast cancer.